← Eichor
Condition: Antiplatelet Therapy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Antiplatelet Therapy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
Phase 3 · 71 location(s) · Capital Medical University · NCT06548971The Bridging Antiplatelet Therapy With Cangrelor 2 Study
Phase 4 · 1 location(s) · University of Florida · NCT07225842Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding
Phase 4 · 1 location(s) · University of Florida · NCT07025148Antithrombotic Therapy After Coronary Artery Bypass Grafting Combined With Coronary Endarterectomy
Phase 4 · 1 location(s) · China National Center for Cardiovascular Diseases · NCT05782270Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI
Phase 4 · 1 location(s) · University of Florida · NCT05681702AERIAL Trial: Antiplatelet Therapy in Heart Transplantation
Phase 3 · 3 location(s) · Ottawa Heart Institute Research Corporation · NCT04770012Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angiop
Phase 3 · 1 location(s) · Cardiocentro Ticino · NCT07582835The Study to Evaluate the Safety and Efficacy of the Onyx Family
Phase N/A · 1 location(s) · Pusan National University Yangsan Hospital · NCT06577896OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in Stable Angina
NA · 1 location(s) · Korea University Guro Hospital · NCT07198529The Safety and Efficacy of Single Antiplatelet Therapy After Pipeline Flex with Shield for Intracranial Aneurysms
Phase N/A · 1 location(s) · Xuanwu Hospital, Beijing · NCT06474884Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic
NA · 1 location(s) · Rajaie Cardiovascular Medical and Research Center · NCT06541691Antiplatelet Therapy and Endothelial-stabilizing Agents in Cerebral Small Vessel Diseases
Phase N/A · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06715007Ticagrelore Alone Post PCI
Phase 4 · 2 location(s) · Shiraz University of Medical Sciences · NCT06509893Multi-Omics-Based Novel Thrombosis and Bleeding Markers and Risk Model for CHD
Phase N/A · 3 location(s) · Xueyan Zhao · NCT07523880AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE
Phase 4 · 2 location(s) · University Hospital, Bordeaux · NCT04796714Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone
Phase 3 · 1 location(s) · Montreal Heart Institute · NCT07257198Endoscopic Evaluation for Iron Deficiency Anemia in Patients on Antithrombotic Therapy
NA · 1 location(s) · Centre intégré universitaire de santé et de services sociaux · NCT07089030Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute M
Phase 3 · 1 location(s) · Samsung Medical Center · NCT07467213Safety and Effectiveness of Short-Term Single AntiPlatelet Therapy After Left Atrial Appendage Closure With the LAmbre D
Phase N/A · 22 location(s) · Fundación EPIC · NCT06620757Cohort of Patients With Left Ventricular Thrombus: Management and Outcomes in the Direct Oral Anticoagulants Era
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT05028777Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion
Phase 4 · 2 location(s) · Samsung Medical Center · NCT04014803Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05577988MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study
Phase 4 · 9 location(s) · CHA University · NCT06543082Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and
NA · 1 location(s) · St. Antonius Hospital · NCT06168370Fexuprazan for Prevention of Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet
NA · 1 location(s) · SUK MIN SEO · NCT07479056Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting On
NA · 1 location(s) · Yonsei University · NCT05320926Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure
Phase 4 · 1 location(s) · National Institute of Cardiology, Warsaw, Poland · NCT03445949Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction
Phase 4 · 6 location(s) · Rikke Sorensen · NCT05262803Algorithm-based Tailoring of Dual Antiplatelet Therapy to Improve Outcomes Following Percutaneous Coronary Interventions
NA · 3 location(s) · Insel Gruppe AG, University Hospital Bern · NCT05732701Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke
Phase 2 · 7 location(s) · The Florey Institute of Neuroscience and Mental Health · NCT05363397
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.